Viking Global Investors LP Ginkgo Bioworks Holdings, Inc. Transaction History

Viking Global Investors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $96 Million - $175 Million	80,000,000 Added 126.81%	143,085,126 $190 Million
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $63.2 Million - $136 Million	-38,749,000 Reduced 38.05%	63,085,126 $107 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $54.6 Million - $280 Million	74,750,000 Added 275.99%	101,834,126 $318 Million
Q2 2022 Aug 15, 2022	SELL	$2.2 - $4.2 $52.7 Million - $101 Million	-23,971,018 Reduced 46.95%	27,084,126 $64.5 Million
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $815 Million - $2.5 Billion	-288,000,000 Reduced 84.94%	51,055,144 $206 Million
Q4 2021 May 16, 2022	BUY	$8.31 - $14.92 $225 Million - $404 Million	27,084,126 Added 8.68%	339,055,144 $2.82 Billion
Q4 2021 Feb 14, 2022	SELL	$8.31 - $14.92 $225 Million - $404 Million	-27,084,126 Reduced 7.99%	311,971,018 $2.59 Billion
Q3 2021 May 16, 2022	BUY	$9.15 - $13.28 $330 Million - $480 Million	36,112,170 Added 11.92%	339,055,144 $3.93 Billion
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $2.77 Billion - $4.02 Billion	302,942,974 New	302,942,974 $3.51 Billion

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.